Comments on Using Existing Data for the Endocrine Screening Testing Lorenz Rhomberg, PhD Principal Gradient ISRTP 2009 Endocrine Workshop.

Slides:



Advertisements
Similar presentations
Perspectives from EPA’s Endocrine Disruptor Screening Program
Advertisements

A SharePoint site is a Web site that provides a central storage and collaboration space for documents, information, and ideas. A SharePoint site is a tool.
UNEP Advisory Group Meeting Geneva, Switzerland December 12, 2014
Richard A. Becker, Ph.D., D.A.B.T American Chemistry Council Arlington, Virginia Comments on “Dose Setting” EDMVS Meeting July 23-24, 2002.
1 Globally Harmonized System of Classification and Labelling of Chemicals (GHS): U.S. Update.
Priority-setting for the Endocrine Disruptor Screening Program: Pesticide Active Ingredients Penelope A. Fenner-Crisp Office of Pesticide Programs U.S.
Endocrine Screening – Phase 1 TSCA 8(e) and FIFRA 6(a)(2) Requirements A. Michael Kaplan, Ph.D. December 13, 2010 A. Michael Kaplan & Associates, LLC
EDSP Validation Gary E.Timm Senior Technical Advisor Office of Science Coordination and Policy U.S. Environmental Protection Agency.
Evolution of ICCVAM ◊National Toxicology Program Develop and validate improved test methods ◊NIH Revitalization Act: P.L Develop and.
Criteria for Screens— Review of the EDSTAC Recommendations Presentation to the EDMVS July 23, 2002.
Quill Law Group LLC1 EDSP Implementation Business and Legal Considerations Terry F. Quill Quill Law Group LLC 1667 K St, NW Washington, DC
Quill Law Group LLC1 EDSP Compliance EDSP Phase 2 Policies and Procedures Terry F. Quill Quill Law Group LLC 1667 K St, NW Washington, DC
Status of the U.S. Endocrine Disruptor Screening Program (EDSP) Status of the U.S. Endocrine Disruptor Screening Program (EDSP) September
Are our Science Graduates Ready for Work? An Environmental Perspective with Proposals for Action Dr Eureta Rosenberg
EDSP’s Approach to Test Protocol Validation Office of Science Coordination and Policy U.S. Environmental Protection Agency.
Quill Law Group LLC1 EDSP Compliance Timing, Procedural and Legal Issues Terry F. Quill Quill Law Group LLC 1667 K St, NW Washington, DC
Multimedia Assessment for New Fuels: Stakeholders’ Meeting September 13, 2005 Sacramento, CA Dean Simeroth, California Air Resources Board Dave Rice, Lawrence.
Slide 1 of 24 EPA’s Endocrine Disruptor Screening Program (EDSP) Use of Exposure Data in Priority Setting Bill Wooge Office of Science Coordination and.
United States Department of Agriculture Food Safety and Inspection Service 1 National Advisory Committee on Meat and Poultry Inspection August 8-9, 2007.
Tracking national portfolios and assessing results Sub-regional Workshop for GEF Focal Points Western and Central Africa Dakar, May 2007.
1 Tier 1 EDSP: Other Scientifically Relevant Information Barbara Neal Exponent December 13, 2010.
Canada’s Federal Environmental Assessment Regime Presentation to the Forum of Federations Environmental Assessment Conference Ottawa, Canada September.
Tribal Science Council Regaining and Protecting “Regaining and Protecting Tribal Culture through Science Tribal Culture through Science” 6th Annual New.
1 The Role of Technology Information in Needs Assessment in Ghana Presented by William K. Agyemang-Bonsu Senior Programme Officer Environmental protection.
International Society of Regulatory Toxicology and Pharmacology 2009 Endocrine Workshop The Endocrine Disruptor Screening Program: What Can Screening Results.
1 The RRFSS Evaluation Framework 2005 Background Information and Progress to Date Presenters  Amira Ali  Jane Hohenadel  Kate O’Connor  Deborah Radcliffe.
Communications and the Endocrine Disruptor Screening Program ISRTP Workshop December 13, 2010.
Quill Law Group LLC1 EDSP Implementation Business and Legal Considerations Terry F. Quill Quill Law Group LLC 1667 K St, NW Washington, DC
EDSP: T IER 1 T ESTING I NFORMATION C OLLECTION ISRTP 2010 Endocrine Workshop EDSP Compliance December 13, 2010 Susan Ferenc, DVM, Ph.D.
1 The United Nations Demographic Yearbook and the Work Programme for Social Statistics Expert Group Meeting to Review the United Nations Demographic Yearbook.
Environmental Assessment Act – Overview Environmental Media Group.
Introduction to Session II: Incorporating Existing Data into the EDSP Erik R. Janus Director, Human Health Policy CropLife America.
RIVER NENE REGIONAL PARK Kathryn Hardcastle Chief Executive Officer “The Nene Integrated Catchment Management pilot – Benefits of Partnership.
Overview of Pesticides and Toxics Research Programs: Safe Pesticides/Safe Products and Endocrine Disruptors Elaine Z. Francis, Ph.D. National Program Director,
Transfer of Technology Consultative Process Wanna Tanunchaiwatana Manager, Technology Climate Change Secretariat (UNFCCC) Asia and the Pacific Regional.
United States Department of Agriculture Food Safety and Inspection Service Overview of Trim Sampling Compliance Guidelines and Discussion Daniel Engeljohn,
EDSP Implementation: Concerns for the Pesticide Industry ISRTP 2009 Endocrine Workshop: The Endocrine Disruptor Screening Program: What Can Screening Results.
R7 Pollinator Protection Workgroup Actions Damon Frizzell U.S. Environmental Protection Agency Region 7 April 21,
Technology Services – National Institute of Standards and Technology Facilitating Global Markets: NIST Dialogue with Regulators Mary Saunders Chief, Standards.
The Regulatory Assistance Project Vermont ♦ Maine ♦ New Mexico ♦ California National Action Plan for Demand Response and PNDRP PNDRP July 15, 2010 Richard.
Endocrine Disruptor Screening and Testing: An Industry Update
FEASIBILITY STUDY Objective 2.13.
Is your business/venture Feasible?
DRAFT TRANSPORT, ENVIRONMENT & HEALTH CHARTER Department of Transport
The GEF Monitoring and Evaluation Policy
WISE PhD proposal June 2017 Student: Dolores Gonzalez
The GEF Monitoring and Evaluation Policy
Title Goes Here Name (s), Organization, CEOS Affiliation CEOS SIT-33
DG Environment, Unit D.2 Marine Environment and Water Industry
Principle 3: Develop DM Processes to Fit the Context and Business Environment in Which They Will Be Performed Learning Objectives: Understand how DM can.
Martin Tuchyňa Towards an INSPIREd e-reporting & INSPIRE priority datasets in Slovakia INSPIRE conference ,
Title Goes Here Name (s), Organization, CEOS Affiliation CEOS SIT-33
National Environmental Policy Act of 1969 (NEPA)
Accommodations Definition Rationale What is the Controversy?
Handout 11: Understanding the organisational environment
State of play endocrine disruptors
The GEF Monitoring and Evaluation Policy
The Well-being of Future Generations Act
Relationship between World Bank and Romanian EA requirements
Executive Order No. 23 Update Air & Waste Management Association Conference November 16, 2018 Presentation will focus on the latest policy development.
Stakeholder Involvement in Nuclear issues Workshop: Milestones for Nuclear Power Infrastructure Development November 5-9, 2007 Why Stakeholders are.
VC Title Goes Here Name (s), Organization, CEOS Affiliation
The GEF Monitoring and Evaluation Policy
WG Title Goes Here Name (s), Organization, CEOS Affiliation
Assessing Students With Disabilities: IDEA and NCLB Working Together
IS YOUR BUSINESS/VENTURE FEASIBLE?
Monitoring and Evaluating FGM/C abandonment programs
Keith Jeffery Aquaculture development & bio-diversity support officer
Pesticides & Children: Ten Years After FQPA
Presentation transcript:

Comments on Using Existing Data for the Endocrine Screening Testing Lorenz Rhomberg, PhD Principal Gradient ISRTP 2009 Endocrine Workshop

Tiers Tier 1 SCREENING Tier 2 TESTING Determine whether substances may interact with the Endocrine System (EAT) Tier 2 TESTING Determine whether substances cause adverse effects Information for HazID (and QRA) WoE Triggers ??

From: U.S. Environmental Protection Agency, Office of Prevention, Pesticides, and Toxic Substances, Office of Science Coordination and Policy. TECHNICAL REVIEW DOCUMENT for ENDOCRINE DISRUPTOR SCREENING PROGRAM (EDSP): PROPOSED TIER 1 SCREENING BATTERY. March 7, 2008.

Validation INTERNAL VALIDITY (Reliability – Rigor, Reproducibility among Laboratories) EXTERNAL VALIDITY (Relevance – meaningful and useful for a particular purpose)

Purposes “Technical” – measure/detect a particular material event or activity e.g., ability to bind to ER Assay-for-assay swap, technically equivalent Validation?

Purposes “Technical” “Functional” – measure/detect/characterize a force, process, or action e.g., interaction with androgen signaling Assays that address the same system and functioning (albeit in a somewhat different way) Equivalent in ability to detect “interaction with endocrine system” False negatives?

Purposes “Technical” “Functional” “Dispositional” – enable the motivating decision e.g., enable the conditional triggering of Tier 2 testing What are triggers? WoE considerations?

Purposes “Technical” “Functional” “Dispositional” “Final” – address the ultimate question e.g., Tier 2 test already done What are Tier 2 tests? What would substitute? Can one (should one) obviate screening?

Thank you for the opportunity to present these ideas